Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Inc. Regulatory News (DIG)

Share Price Information for Dunedin Inc. (DIG)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.00 (0.00%)
Bid:
302.00
Ask:
305.00
Spread: 3.00 (0.993%)
Market Cap: £356.03m
DIG Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Inc. Share Chart

Board Changes

31 Jan 2025 10:43

RNS Number : 4807V
Dunedin Income Growth Inv Tst PLC
31 January 2025
Β 

Dunedin Income Growth Investment Trust PLC

Legal Entity Identifier (LEI): 549300PPXLZPR5JTL763

Β 

Β 

Β 

31 January 2025

Β 

Β 

Board Changes

The Board of Dunedin Income Growth Investment Trust PLC (the "Company") is pleased to announce the appointment of Arun Kumar Sarwal as an independent non-executive Director of the Company with effect from 1 February 2025.Β 

Β 

Arun Kumar Sarwal is a Chartered Accountant and has broad experience of global equities and fund management over some 35Β years in the UK, Europe, and Asia. He is a Board Advisor to Tumelo and a director and Chairman of the Audit Committee of JPMorgan European Discovery Trust plc. His previous roles include CEO of Broadridge Fund Communication Solutions, Senior Vice President of SS&C Technologies, COO and CFO at Scottish Widows Investment Partnership and global roles at ABN AMRO and Societe Generale Investment Bank.

Β 

Arun will stand for election at the Annual General Meeting to be held in May 2025. There are no other disclosures required under Section 6.4.8 of the FCA's Listing Rules in relation to this appointment.

Β 

As previously stated, Jasper Judd and David Barron, who both joined the Board in February 2016 will retire as Directors at the conclusion of the Company's Annual General Meeting in May. It is the Board's intention that Arun Kumar Sarwal will be appointed as Chairman of the Audit Committee in place of Jasper Judd at that time. As previously stated, Howard Williams, who has been a Director since April 2018, will succeed David Barron as Chair of the Company following the AGM.

Β 

It is the Board's intention to recruit a further Director in 2025 to bring the number of Directors back to five.

Β 

Β 

Β 

For further information, please contact:

Β 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAPKDBQKBKDBDN
Date   Source Headline
4th Feb 202611:05 amRNSNet Asset Value(s)
3rd Feb 20266:00 pmRNSQuarterly Disclosures
3rd Feb 20265:15 pmRNSTransaction in Own Shares
3rd Feb 202612:45 pmRNSNet Asset Value(s)
2nd Feb 20264:11 pmRNSGearing disclosure
2nd Feb 202610:17 amRNSTotal Voting Rights
30th Jan 202612:19 pmRNSNet Asset Value(s)
29th Jan 202612:19 pmRNSNet Asset Value(s)
28th Jan 20265:20 pmRNSTransaction in Own Shares
28th Jan 202611:35 amRNSNet Asset Value(s)
27th Jan 202611:46 amRNSNet Asset Value(s)
26th Jan 20262:37 pmRNSGearing disclosure
26th Jan 202612:25 pmRNSNet Asset Value(s)
23rd Jan 202612:27 pmRNSNet Asset Value(s)
22nd Jan 20265:15 pmRNSTransaction in Own Shares
22nd Jan 202611:50 amRNSNet Asset Value(s)
21st Jan 20265:06 pmRNSTransaction in Own Shares
21st Jan 202611:57 amRNSNet Asset Value(s)
20th Jan 202612:04 pmRNSNet Asset Value(s)
19th Jan 20265:03 pmRNSTransaction in Own Shares
19th Jan 20262:44 pmRNSGearing disclosure
19th Jan 202612:27 pmRNSNet Asset Value(s)
16th Jan 202610:44 amRNSNet Asset Value(s)
15th Jan 202611:07 amRNSNet Asset Value(s)
14th Jan 202611:35 amRNSNet Asset Value(s)
13th Jan 202611:21 amRNSNet Asset Value(s)
12th Jan 20261:04 pmRNSGearing disclosure
12th Jan 202612:10 pmRNSNet Asset Value(s)
12th Jan 20269:38 amRNSPortfolio disclosure
9th Jan 202612:16 pmRNSNet Asset Value(s)
8th Jan 202611:33 amRNSNet Asset Value(s)
7th Jan 202611:40 amRNSNet Asset Value(s)
6th Jan 20265:38 pmRNSMonth End Net Asset Value(s)
6th Jan 202611:16 amRNSNet Asset Value(s)
5th Jan 20261:06 pmRNSGearing disclosure
5th Jan 202612:29 pmRNSNet Asset Value(s)
2nd Jan 20269:59 amRNSTotal Voting Rights
31st Dec 202511:14 amRNSNet Asset Value(s)
30th Dec 202511:30 amRNSNet Asset Value(s)
29th Dec 202511:54 amRNSGearing disclosure
29th Dec 202511:54 amRNSGearing disclosure
29th Dec 202511:44 amRNSNet Asset Value(s)
24th Dec 202512:18 pmRNSNet Asset Value(s)
23rd Dec 202512:48 pmRNSNet Asset Value(s)
22nd Dec 20255:10 pmRNSTransaction in Own Shares
22nd Dec 20255:10 pmRNSTransaction in Own Shares
22nd Dec 20251:38 pmRNSGearing Disclosures
22nd Dec 20251:38 pmRNSGearing Disclosures
22nd Dec 202512:28 pmRNSNet Asset Value(s)
19th Dec 20255:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.